Venlafaxine ER Dosing Recommendations
Start venlafaxine ER at 75 mg once daily in the morning with food, and titrate to 150-225 mg/day based on response, with dose increases of up to 75 mg at intervals of no less than 4 days 1.
Standard Adult Dosing
- Initial dose: 75 mg once daily
- Target therapeutic range: 150-225 mg/day for most outpatients with moderate depression
- Maximum dose: 225 mg/day for outpatients; up to 375 mg/day may be considered for severely depressed inpatients who demonstrate inadequate response 1
- Titration schedule: Increase by up to 75 mg increments at intervals of at least 4 days between adjustments
The extended-release formulation demonstrated superiority over immediate-release at 12 weeks and offers the convenience of once-daily dosing with comparable efficacy 2.
Dose Adjustments for Special Populations
Renal Impairment
Reduce the total daily dose by 25% in mild to moderate renal impairment (GFR 10-70 mL/min), and by 50% in patients on hemodialysis 1.
The pharmacokinetic rationale is clear: venlafaxine clearance decreases by approximately 55% in dialysis patients, with significantly prolonged half-life for both venlafaxine and its active metabolite O-desmethylvenlafaxine 3. Recent evidence confirms that even mild renal impairment (GFR stages 2-3) significantly affects venlafaxine serum concentrations in geriatric patients, making therapeutic drug monitoring advisable to prevent overdosing 4. Note that venlafaxine and its metabolite are poorly dialyzable 3.
Hepatic Impairment
Reduce the total daily dose by 50% in patients with mild to moderate hepatic impairment or cirrhosis 1.
Hepatic impairment decreases clearance and increases elimination half-life for both venlafaxine and O-desmethylvenlafaxine. Individual variability is substantial in cirrhotic patients, so some may require reductions exceeding 50% 1.
Elderly Patients
No routine dose adjustment is required based on age alone, but exercise extra caution when titrating doses upward 1.
While age per se does not mandate dose reduction, elderly patients frequently have concurrent renal impairment or multimorbidity that affects drug metabolism 5, 6. The combination of decreased GFR (even mild impairment) has a more pronounced effect on venlafaxine concentrations than age or sex alone in geriatric populations 4. Monitor blood pressure carefully, as treatment-emergent hypertension occurs more commonly at doses above 150 mg/day in older patients 6.
Critical Monitoring Considerations
- Blood pressure: Monitor supine diastolic blood pressure, particularly at doses >150 mg/day, as venlafaxine may cause dose-dependent increases 5, 6
- Serum cholesterol: Consider monitoring during long-term treatment 1
- Cardiac considerations: Exercise caution in patients with recent MI, unstable heart disease, or conditions that could be compromised by heart rate increases (mean increase of 4-8.5 beats/minute depending on dose) 1
Discontinuation Protocol
Taper gradually rather than stopping abruptly; if intolerable withdrawal symptoms occur, resume the previous dose and decrease more slowly 1.
Discontinuation symptoms are well-documented with venlafaxine and other SNRIs. A gradual dose reduction minimizes withdrawal effects.
MAOI Interactions
- Allow 14 days after stopping an MAOI before starting venlafaxine
- Allow 7 days after stopping venlafaxine before starting an MAOI 1
- Do not use with linezolid or IV methylene blue due to serotonin syndrome risk 1
Maintenance Treatment
Continue the same dose that achieved acute response for maintenance therapy. Acute episodes require several months or longer of sustained treatment beyond initial response, with efficacy demonstrated for maintenance doses of 75-225 mg/day over 26-52 weeks 1.